Mid Cap Emerging Biopharmaceutical Companies: Valuations Do Matter for M&A

Valuation Models for  Biopharma Stocks -M&A Update In October 2013 we compared emerging biotech stocks after the acquistion of Onyxx Pharmaceuticals by Amgen (AMGN). Now that rumors are “out there” for the acquisition of Pharmacyclics (PCYC) by large healthcare companies such as Johnson and Johnson (JNJ) and Novartis (NVS) we can compare valuations. The $11B++ […]

Continue Reading 0

SierraSnow Blog 2/27-3/3/15…. More Snowpack

More snow coming this weekend: Jet Stream  in Place earth :: an animated map of global wind, weather, and ocean conditions National Maps – NOAA’s National Weather Service 814prcp.new.gif 719×759 pixels Colder wetter bringing 12 in.+ Mammoth Lakes Weather brought to you by Howard Sheckter  

Continue Reading 0

Rayno Biopharmaceutical Stocks: PCYC Buzz Drive Biotechs Higher… Update-1

2/27 Friday After a big February biotechs turned red today with major ETFs off about 1%. In light of recent M&A talk about Pharmacyclics, Inc. (PCYC) at Market Cap of $16.6B we will look at other top Mid-Cap biopharmaceutical stocks for comparison to our motif below: ALNY, BMRN, INCY, MDVN, PBYI etc. Rayno Mid-Caps Outperform […]

Continue Reading 0

Rayno Dx and Tools: Update EXAS

Valuation Does Matter If Revenue Growth Slows Last week we posted a YTD summary of our diagnostics and tools focus stocks. Three stocks that are up over one year but have been weak in 2015. We said that revenue guidance and technicals will be important for: Exact Sciences (EXAS), Genomic Health (GHDX) and Neogen (NEOG). […]

Continue Reading 0

SierraSnowBlog: Tiny Bit of Relief Coming Up…Update 2/23 Powder Day

2/23/15 I was at Mammoth Mountain today with light winds, partly sunny, temp in 20s. There was 8-12 in of light powder with great runs off Chairs 1, 2, 3 and 12 in early am. Stay tuned for March forecast. Colder With Some New Cover Even NOAA confirms precipitation and colder weather ahead beginning Sunday. […]

Continue Reading 0